FEBUXOSTAT is a xanthine oxidase (XO) inhibitor indicated for the chronic management of hyperuricemia in patients with gout.
FEBUXOSTAT is not recommended for the treatment of asymptomatic hyperuricemia.
Other Services
Country
Account